Pharmaceuticals

Pharma MNCs focus on branded generics in India to drive growth

14 Sep 2010

Daiichi Sankyo gets approval for influenza drugh Ianivir

13 Sep 2010

Genzyme to sell genetic testing business to LabCorp for $925 million

13 Sep 2010

3M to buy patient warming products maker Arizant for $810 million

11 Sep 2010

Abbott to keep Piramal business separate after acquisition

11 Sep 2010

With Paras Pharma keen to sell, Emami ready to buy

09 Sep 2010

Sanofi Aventis reportedly raises offer to $71 per share

09 Sep 2010

Israel Supreme Court lifts injunction on Sun's acquisition of Taro

08 Sep 2010

Sun Pharma subsidiary, which holds a 36 per cent stake in Taro, said it plans to move forward to close the offer and enforce its rights under the option agreement to purchase the Levitts' controlling shares

Bristol-Myers Squibb offers 84-% premium to buy ZymoGenetics for $885 million

08 Sep 2010

UK regulator moots withdrawing GSK’s Avandia drug from UK market

06 Sep 2010

Novartis aqnnounces novel antimalarial drug

06 Sep 2010

GSK investigates Pandermix link to chronic sleep disorder

04 Sep 2010

Orexigen, Takeda in $1-billion deal for obesity drug

03 Sep 2010

Vitamin D found to influence over 200 genes, highlighting links to disease

02 Sep 2010

Allergan to pay $600 million to settle US probe on anti-wrinkle treatment drug

02 Sep 2010

Pfizer to acquire FoldRx Pharmaceuticalsing

01 Sep 2010

USFDA approves Sun's generic version of Lilly's Strattera

01 Sep 2010

Genzyme board rejects Sanofi-Aventis $18.5-billion takeover offer

31 Aug 2010

Sanofi-Aventis reveals $18.5-billion offer for Genzyme

30 Aug 2010

J&J unit DePuy issues global recall of 93,000 hip replacement systems

27 Aug 2010

Cipla to acquire formulations maker Meditab for Rs133.35 crore

25 Aug 2010

Roche bets $1.1 billion on Aileron Therapeutics stapled peptide

25 Aug 2010

Medical isotopes shortage likely to push up medical scan costs

25 Aug 2010

Industry ministry suggests mandatory third party licensing of patented drugs

24 Aug 2010

The compulsory licensing mechanism rewards inventions while making them available to the public and is fully WTO-compliant.

Roche to buy cancer diagnostic firm BioImagene Inc for $100 million

24 Aug 2010